Jan 22 (Reuters) - AnGes Inc :
* Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI)
Source text in Japanese: goo.gl/DKLSkV
Further company coverage: (Beijing Headline News)
 